Pioglitazone, a drug used in the treatment of diabetes mellitus, is a peroxisome proliferator-activated receptor-gamma (PPAR-gamma) agonist which increases expression of the PPAR-gamma gene, reducing glucose and subsequently reducing CVS risk. The gene discussed is PPARG; the disease is diabetes mellitus.